Machine learning developed immune-related exosome signature for prognosis and immunotherapy benefit in bladder cancer
The current study developed an optimal IES in bladder cancer, which acted as an indicator for predicting clinical outcome and immunotherapy benefits for bladder cancer patients.
Authors
- Xinyu Luo (ORCID: https://orcid.org/0000-0002-4975-6330)
- Yi Luo (ORCID: https://orcid.org/0000-0003-0087-5045)
Institutions
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1007/s12672-025-02354-0
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01